The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

Vaccine

Volumn 23, Issue 17-18, 2005, Pages 2269-2272

  Okada, Masaji ^a   Takemoto, Yuji ^a   Okuno, Yoshinobu ^b   Hashimoto, Satomi ^a   Yoshida, Shigeto ^c   Fukunaga, Yukari ^a   Tanaka, Takao ^a   Kita, Yoko ^a   Kuwayama, Sachiko ^a   Muraki, Yumiko ^a   Kanamaru, Noriko ^a   Takai, Hiroko ^a   Okada, Chika ^a   Sakaguchi, Yayoi ^a   Furukawa, Izumi ^a   Yamada, Kyoko ^a   Matsumoto, Makoto ^d   Kase, Tetsuo ^b   Demello, Daphne E ^e   Peiris, J S M ^f   Chen, Pei Jer ^g   Yamamoto, Naoki ^h   Yoshinaka, Yoshiyuki ^h   Nomura, Tatsuji ⁱ   Ishida, Isao ^j   Morikawa, Shigeru ^k   Tashiro, Masato ^k   Sakatani, Mitsunori ^a   more..

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁱ CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^j KIRIN BREWERY CO LTD   (Japan)

^k NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

more..

Author keywords

Human CTL; Sars DNA vaccine; SCID PBL hu

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; DNA; DNA VACCINE; ENVELOPE PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; M PROTEIN; NUCLEOCAPSID PROTEIN; PLASMID VECTOR; VIRUS DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROLIFERATION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; LUNG ALVEOLUS CELL; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE; VACCINATION;

EID: 84984588900     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.036     Document Type: Conference Paper

References (9)

1. J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, and W. Lim SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 9366 2003 1319 1325
2. C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H.R. Brodt, and S. Becker Identification of a novel coronavirus in patients with severe acute respiratory syndrome N Engl J Med. 348 20 2003 1967 1976
3. J.S. Peiris, K.Y. Yuen, A.D. Osterhaus, and K. Stohr The severe acute respiratory syndrome N Engl J Med 349 25 2003 2431 2441
4. F. Tanaka, M. Abe, T. Akiyoshi, T. Nomura, K. Sugimachi, and T. Kishimoto The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector Cancer Res. 57 7 1997 1335 1343
5. M. Okada, N. Yoshimura, T. Kaieda, Y. Yamamura, and T. Kishimoto Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules Proc Natl Acad Sci USA 78 12 1981 7717 7721
6. D.E. deMello, S. Mahmoud, P.J. Padfield, and J.W. Hoffmann Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse In Vitro Cell Dev Biol Anim 36 6 2000 374 382
7. W. Gao, A. Tamin, A. Soloff, L. D'Aiuto, E. Nwanegbo, and P.D. Robbins Effects of a SARS-associated coronavirus vaccine in monkeys Lancet 362 9399 2003 1895 1896
8. Z.Y. Yang, W.P. Kong, Y. Huang, A. Roberts, B.R. Murphy, and K. Subbarao A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Nature 428 6982 2004 561 564
9. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, and M.A. Berne Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 2003 450 454